牛逼的基金经理，又限购了

Core Viewpoint - Gao Nan's funds have achieved historical highs despite recent market fluctuations, driven by strong performance and explosive growth in fund size [1][8]. Fund Performance - Yongying Stable Enhancement fund's size increased from 1 billion to 34.9 billion this year, and it has paused institutional subscriptions through third-party channels [1]. - Yongying Ruixin, a flagship fund managed by Gao Nan, has risen by 86.93% this year, with its size growing from 1.3 billion to 14.4 billion [1]. Investment Strategy - Gao Nan employs a bottom-up investment approach, focusing on fundamental improvements and explosive earnings opportunities, successfully capturing turning points in the market [2][3]. - The fund exhibits high turnover rates, with Yongying Ruixin's turnover rate at 780% last year and 856% in the first half of this year, consistent with previous performance at other firms [4]. Sector Allocation - In the first half of 2024, the fund's major sectors include electronics (semiconductors), light industry manufacturing (new consumption), power equipment, non-ferrous metals, and military industry [5]. - The pharmaceutical sector (innovative drugs) became the largest holding in the first half of the year, while light industry manufacturing's allocation decreased [5]. Performance Analysis - In 2024, the fund avoided early-year declines and outperformed the benchmark index from April to May, achieving an 11.8% increase [7][8]. - Despite a slight underperformance in the third quarter due to reduced stock positions and lagging heavyweights, the fund still outperformed the benchmark by 12 percentage points for the year [8]. Future Outlook - In 2025, the fund capitalized on opportunities in new consumption, innovative drugs, and AI, with strong performance across multiple quarters [9][10]. - The fund's performance in the fourth quarter has also been solid, with a 5.5% increase and a top 4 ranking among peers [11].